276 related articles for article (PubMed ID: 18658135)
1. Increased dosage of Dyrk1A alters alternative splicing factor (ASF)-regulated alternative splicing of tau in Down syndrome.
Shi J; Zhang T; Zhou C; Chohan MO; Gu X; Wegiel J; Zhou J; Hwang YW; Iqbal K; Grundke-Iqbal I; Gong CX; Liu F
J Biol Chem; 2008 Oct; 283(42):28660-9. PubMed ID: 18658135
[TBL] [Abstract][Full Text] [Related]
2. Dual-specificity tyrosine phosphorylation-regulated kinase 1A (Dyrk1A) modulates serine/arginine-rich protein 55 (SRp55)-promoted Tau exon 10 inclusion.
Yin X; Jin N; Gu J; Shi J; Zhou J; Gong CX; Iqbal K; Grundke-Iqbal I; Liu F
J Biol Chem; 2012 Aug; 287(36):30497-506. PubMed ID: 22767602
[TBL] [Abstract][Full Text] [Related]
3. Link between DYRK1A overexpression and several-fold enhancement of neurofibrillary degeneration with 3-repeat tau protein in Down syndrome.
Wegiel J; Kaczmarski W; Barua M; Kuchna I; Nowicki K; Wang KC; Wegiel J; Yang SM; Frackowiak J; Mazur-Kolecka B; Silverman WP; Reisberg B; Monteiro I; de Leon M; Wisniewski T; Dalton A; Lai F; Hwang YW; Adayev T; Liu F; Iqbal K; Iqbal IG; Gong CX
J Neuropathol Exp Neurol; 2011 Jan; 70(1):36-50. PubMed ID: 21157379
[TBL] [Abstract][Full Text] [Related]
4. Regulation of the alternative splicing of tau exon 10 by SC35 and Dyrk1A.
Qian W; Liang H; Shi J; Jin N; Grundke-Iqbal I; Iqbal K; Gong CX; Liu F
Nucleic Acids Res; 2011 Aug; 39(14):6161-71. PubMed ID: 21470964
[TBL] [Abstract][Full Text] [Related]
5. Dyrk1A overexpression leads to increase of 3R-tau expression and cognitive deficits in Ts65Dn Down syndrome mice.
Yin X; Jin N; Shi J; Zhang Y; Wu Y; Gong CX; Iqbal K; Liu F
Sci Rep; 2017 Apr; 7(1):619. PubMed ID: 28377597
[TBL] [Abstract][Full Text] [Related]
6. Truncation and Activation of Dual Specificity Tyrosine Phosphorylation-regulated Kinase 1A by Calpain I: A MOLECULAR MECHANISM LINKED TO TAU PATHOLOGY IN ALZHEIMER DISEASE.
Jin N; Yin X; Gu J; Zhang X; Shi J; Qian W; Ji Y; Cao M; Gu X; Ding F; Iqbal K; Gong CX; Liu F
J Biol Chem; 2015 Jun; 290(24):15219-37. PubMed ID: 25918155
[TBL] [Abstract][Full Text] [Related]
7. Regulation of alternative splicing of tau exon 10 by 9G8 and Dyrk1A.
Ding S; Shi J; Qian W; Iqbal K; Grundke-Iqbal I; Gong CX; Liu F
Neurobiol Aging; 2012 Jul; 33(7):1389-99. PubMed ID: 21215488
[TBL] [Abstract][Full Text] [Related]
8. Cyclic AMP-dependent protein kinase regulates the alternative splicing of tau exon 10: a mechanism involved in tau pathology of Alzheimer disease.
Shi J; Qian W; Yin X; Iqbal K; Grundke-Iqbal I; Gu X; Ding F; Gong CX; Liu F
J Biol Chem; 2011 Apr; 286(16):14639-48. PubMed ID: 21367856
[TBL] [Abstract][Full Text] [Related]
9. The role of DYRK1A in neurodegenerative diseases.
Wegiel J; Gong CX; Hwang YW
FEBS J; 2011 Jan; 278(2):236-45. PubMed ID: 21156028
[TBL] [Abstract][Full Text] [Related]
10. The role of overexpressed DYRK1A protein in the early onset of neurofibrillary degeneration in Down syndrome.
Wegiel J; Dowjat K; Kaczmarski W; Kuchna I; Nowicki K; Frackowiak J; Mazur Kolecka B; Wegiel J; Silverman WP; Reisberg B; Deleon M; Wisniewski T; Gong CX; Liu F; Adayev T; Chen-Hwang MC; Hwang YW
Acta Neuropathol; 2008 Oct; 116(4):391-407. PubMed ID: 18696092
[TBL] [Abstract][Full Text] [Related]
11. DYRK1A-mediated hyperphosphorylation of Tau. A functional link between Down syndrome and Alzheimer disease.
Ryoo SR; Jeong HK; Radnaabazar C; Yoo JJ; Cho HJ; Lee HW; Kim IS; Cheon YH; Ahn YS; Chung SH; Song WJ
J Biol Chem; 2007 Nov; 282(48):34850-7. PubMed ID: 17906291
[TBL] [Abstract][Full Text] [Related]
12. Normalizing the gene dosage of Dyrk1A in a mouse model of Down syndrome rescues several Alzheimer's disease phenotypes.
García-Cerro S; Rueda N; Vidal V; Lantigua S; Martínez-Cué C
Neurobiol Dis; 2017 Oct; 106():76-88. PubMed ID: 28647555
[TBL] [Abstract][Full Text] [Related]
13. Transactive response DNA-binding protein 43 (TDP-43) regulates alternative splicing of tau exon 10: Implications for the pathogenesis of tauopathies.
Gu J; Chen F; Iqbal K; Gong CX; Wang X; Liu F
J Biol Chem; 2017 Jun; 292(25):10600-10612. PubMed ID: 28487370
[TBL] [Abstract][Full Text] [Related]
14. Protein phosphatase PPM1B inhibits DYRK1A kinase through dephosphorylation of pS258 and reduces toxic tau aggregation.
Lee YH; Im E; Hyun M; Park J; Chung KC
J Biol Chem; 2021; 296():100245. PubMed ID: 33380426
[TBL] [Abstract][Full Text] [Related]
15. Engineering DYRK1A overdosage yields Down syndrome-characteristic cortical splicing aberrations.
Toiber D; Azkona G; Ben-Ari S; Torán N; Soreq H; Dierssen M
Neurobiol Dis; 2010 Oct; 40(1):348-59. PubMed ID: 20600907
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of Dyrk1A contributes to neurofibrillary degeneration in Down syndrome.
Liu F; Liang Z; Wegiel J; Hwang YW; Iqbal K; Grundke-Iqbal I; Ramakrishna N; Gong CX
FASEB J; 2008 Sep; 22(9):3224-33. PubMed ID: 18509201
[TBL] [Abstract][Full Text] [Related]
17. Dual-specificity tyrosine phosphorylation-regulated kinase 1A promotes the inclusion of amyloid precursor protein exon 7.
Chu D; Lei L; Gu S; Liu F; Wu F
Biochem Pharmacol; 2024 Jun; 224():116233. PubMed ID: 38663682
[TBL] [Abstract][Full Text] [Related]
18. HIV-1-Tat Protein Inhibits SC35-mediated Tau Exon 10 Inclusion through Up-regulation of DYRK1A Kinase.
Kadri F; Pacifici M; Wilk A; Parker-Struckhoff A; Del Valle L; Hauser KF; Knapp PE; Parsons C; Jeansonne D; Lassak A; Peruzzi F
J Biol Chem; 2015 Dec; 290(52):30931-46. PubMed ID: 26534959
[TBL] [Abstract][Full Text] [Related]
19. Constitutive Dyrk1A is abnormally expressed in Alzheimer disease, Down syndrome, Pick disease, and related transgenic models.
Ferrer I; Barrachina M; Puig B; Martínez de Lagrán M; Martí E; Avila J; Dierssen M
Neurobiol Dis; 2005 Nov; 20(2):392-400. PubMed ID: 16242644
[TBL] [Abstract][Full Text] [Related]
20. An SRp75/hnRNPG complex interacting with hnRNPE2 regulates the 5' splice site of tau exon 10, whose misregulation causes frontotemporal dementia.
Wang Y; Wang J; Gao L; Stamm S; Andreadis A
Gene; 2011 Oct; 485(2):130-8. PubMed ID: 21723381
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
